Diagnosis and Treatment > Signs and Symptoms > Skin pigmentation - spotty

You are looking at 1 - 4 of 4 items

Valeria de Miguel Departments of Endocrinology, Metabolism and Nuclear Medicine

Search for other papers by Valeria de Miguel in
Google Scholar
PubMed
Close
,
Andrea Paissan Departments of Endocrinology, Metabolism and Nuclear Medicine

Search for other papers by Andrea Paissan in
Google Scholar
PubMed
Close
,
Patricio García Marchiñena Departments of Urology, Metabolism and Nuclear Medicine

Search for other papers by Patricio García Marchiñena in
Google Scholar
PubMed
Close
,
Alberto Jurado Departments of Urology, Metabolism and Nuclear Medicine

Search for other papers by Alberto Jurado in
Google Scholar
PubMed
Close
,
Mariana Isola Pathology, Buenos Aires, Argentina

Search for other papers by Mariana Isola in
Google Scholar
PubMed
Close
,
José Alfie Hypertension Unit of Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Search for other papers by José Alfie in
Google Scholar
PubMed
Close
, and
Patricia Fainstein-Day Departments of Endocrinology, Metabolism and Nuclear Medicine

Search for other papers by Patricia Fainstein-Day in
Google Scholar
PubMed
Close

Summary

We present the case of a 25-year-old male with a history of neurofibromatosis type 1 and bilateral pheochromocytoma 4 years after kidney transplantation that was successfully treated with simultaneous bilateral posterior retroperitoneoscopic adrenalectomy.

Learning points:

  • Hypertensive patients with NF1 should always be screened for pheochromocytoma.

  • Pheochromocytoma is rarely associated with transplantation, but it must be ruled out in patients with genetic susceptibility.

  • Posterior retroperitoneoscopic adrenalectomy (PRA) allows more direct access to the adrenal glands, especially in patients with previous abdominal surgeries.

Open access
Catherine D Zhang Departments of Internal Medicine, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Catherine D Zhang in
Google Scholar
PubMed
Close
,
Pavel N Pichurin Departments of Clinical Genomics, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Pavel N Pichurin in
Google Scholar
PubMed
Close
,
Aleh Bobr Departments of Laboratory Medicine and Pathology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Aleh Bobr in
Google Scholar
PubMed
Close
,
Melanie L Lyden Departments of Surgery, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Melanie L Lyden in
Google Scholar
PubMed
Close
,
William F Young Jr Departments of Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by William F Young Jr in
Google Scholar
PubMed
Close
, and
Irina Bancos Departments of Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Irina Bancos in
Google Scholar
PubMed
Close

Summary

Carney complex (CNC) is a rare multiple neoplasia syndrome characterized by spotty pigmentation of the skin and mucosa in association with various non-endocrine and endocrine tumors, including primary pigmented nodular adrenocortical disease (PPNAD). A 20-year-old woman was referred for suspected Cushing syndrome. She had signs of cortisol excess as well as skin lentigines on physical examination. Biochemical investigation was suggestive of corticotropin (ACTH)-independent Cushing syndrome. Unenhanced computed tomography scan of the abdomen did not reveal an obvious adrenal mass. She subsequently underwent bilateral laparoscopic adrenalectomy, and histopathology was consistent with PPNAD. Genetic testing revealed a novel frameshift pathogenic variant c.488delC/p.Thr163MetfsX2 (ClinVar Variation ID: 424516) in the PRKAR1A gene, consistent with clinical suspicion for CNC. Evaluation for other clinical features of the complex was unrevealing. We present a case of PPNAD-associated Cushing syndrome leading to the diagnosis of CNC due to a novel PRKAR1A pathogenic variant.

Learning points:

  • PPNAD should be considered in the differential for ACTH-independent Cushing syndrome, especially when adrenal imaging appears normal.

  • The diagnosis of PPNAD should prompt screening for CNC.

  • CNC is a rare multiple neoplasia syndrome caused by inactivating pathogenic variants in the PRKAR1A gene.

  • Timely diagnosis of CNC and careful surveillance can help prevent potentially fatal complications of the disease.

Open access
Dimitrios Haidopoulos Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, 80 Vas Sofias Avenue, Athens, Greece

Search for other papers by Dimitrios Haidopoulos in
Google Scholar
PubMed
Close
,
George Bakolas Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, 80 Vas Sofias Avenue, Athens, Greece

Search for other papers by George Bakolas in
Google Scholar
PubMed
Close
, and
Lina Michala Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens, 80 Vas Sofias Avenue, Athens, Greece

Search for other papers by Lina Michala in
Google Scholar
PubMed
Close

Summary

Turner syndrome (TS) has been linked to a number of autoimmune conditions, including lichen sclerosus (LS), at an estimated prevalence of 17%. LS is a known precursor to vulvar cancer. We present a case of vulvar cancer in a 44-year-old woman, who had previously complained of pruritus in the area, a known symptom of LS. Histology confirmed a squamous cell carcinoma with underlying LS. Vulvar assessment for the presence of LS should be undertaken regularly as part of the routine assessments proposed for adult TS women. If LS is identified, then the patient should be warned of the increased risk of vulvar cancer progression and should be monitored closely for signs of the condition.

Learning points

  • Patients with TS are at increased risk of developing LS.

  • LS is a known precursor to vulvar cancer.

  • TS women with LS may be at risk of developing vulvar cancer and should be offered annual vulvar screening and also be aware of signs and symptoms of early vulvar cancer.

Open access
Hiroto Minamino The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan
Department of Diabetes and Endocrinology, Wakayama Red Cross Hospital, Wakayama, Japan

Search for other papers by Hiroto Minamino in
Google Scholar
PubMed
Close
,
Hidefumi Inaba The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan

Search for other papers by Hidefumi Inaba in
Google Scholar
PubMed
Close
,
Hiroyuki Ariyasu The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan

Search for other papers by Hiroyuki Ariyasu in
Google Scholar
PubMed
Close
,
Hiroto Furuta The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan

Search for other papers by Hiroto Furuta in
Google Scholar
PubMed
Close
,
Masahiro Nishi The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan

Search for other papers by Masahiro Nishi in
Google Scholar
PubMed
Close
,
Takashi Yoshimasu Department of Dermatology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Takashi Yoshimasu in
Google Scholar
PubMed
Close
,
Akinori Nishikawa Department of Hematology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Akinori Nishikawa in
Google Scholar
PubMed
Close
,
Masanori Nakanishi Department of Respiratory Medicine & Medical Oncology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Masanori Nakanishi in
Google Scholar
PubMed
Close
,
Shigeki Tsuchihashi Department of Otolaryngology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Shigeki Tsuchihashi in
Google Scholar
PubMed
Close
,
Fumiyoshi Kojima Department of Human Pathology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Fumiyoshi Kojima in
Google Scholar
PubMed
Close
,
Shin-ichi Murata Department of Human Pathology, Wakayama Medical University, Wakayama, Japan

Search for other papers by Shin-ichi Murata in
Google Scholar
PubMed
Close
,
Gen Inoue Department of Diabetes and Endocrinology, Wakayama Red Cross Hospital, Wakayama, Japan

Search for other papers by Gen Inoue in
Google Scholar
PubMed
Close
, and
Takashi Akamizu The First Department of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan

Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
Close

Summary

A 73-year-old man with Hashimoto's thyroiditis (HT) suffered from purpura on the lower legs. He was diagnosed with IgG4-related disease (IgG4-RD) with serum IgG4 elevation and dacryo-sialadenitis confirmed histologically. Serum Th2 and Treg cytokines, interleukin 7 (IL7), IL8 and Th2 chemokine levels were elevated, while skewed Th1 balance was seen in fluorescence-activated cell sorting (FACS). Therefore, preferential Th1 balance in HT appeared to be followed by IgG4-RD characterized with Th2 and Treg polarization. The commencement of steroid therapy dramatically exacerbated clinical manifestations including IgG4-RD-associated HT. The measurement of cytokine and chemokine levels as well as FACS analysis in the development of IgG4-RD seemed to be beneficial. In conclusion, an innovative association of HT, IgG4-RD and vasculitis was observed. This report also offers novel diagnostic and therapeutic approaches for IgG4-RD.

Learning points

  • Recently, a subtype of HT has been considered to be a thyroid manifestation of IgG4-RD, although the etiology of IgG4-RD is not established yet.

  • Immunologically a close association between HT and vasculitis was reported.

  • Leukocytoclastic vasculitis is a rare skin presentation of IgG4-RD.

  • In the current case, during the course of HT, IgG4-RD and leukocytoclastic vasculitis occurred; thus, innate immunity and acquired immunity seem to be involved in the development of IgG4-RD.

  • The measurement of cytokine and chemokines appeared to be beneficial in the development of IgG4-RD.

  • Remarkably, effectiveness of steroid therapy for HT suggested presence of IgG4-RD-associated HT. Therefore, this report highlights the pathogenesis of IgG4-RD and proposes novel therapeutic mechanisms. Clinicians should pay attention to the development of IgG4-RD and vasculitis during long course of HT.

Open access